Arcus Biosciences (RCUS) Net Income Growth (5y) (2022 - 2026)
Arcus Biosciences (RCUS) Net Income Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,380.63 Bn | 66,380.34 Bn | - |
| 2 | Nanobiotix | 1,910.39 Bn | 1,910.33 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 470.95 Bn | 466.16 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.58 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.52 Bn | 2.70 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.01% |
| Dec 31, 2025 | -14.42% |
| Sep 30, 2025 | -137.83% |
| Mar 31, 2025 | -32.18% |
| Dec 31, 2024 | -37.66% |
| Sep 30, 2024 | -33.14% |
| Jun 30, 2024 | -27.43% |
| Mar 31, 2024 | 25.34% |
| Dec 31, 2023 | -13.66% |
| Sep 30, 2023 | -46.21% |
| Jun 30, 2023 | -38.70% |
| Mar 31, 2023 | -44.43% |
| Dec 31, 2022 | -35.56% |
| Sep 30, 2022 | -22.95% |
| Jun 30, 2022 | -47.29% |
| Mar 31, 2022 | -56.26% |